Sequential Immunization with gp140 Boosts Immune Responses Primed by Modified Vaccinia Ankara or DNA in HIV-Uninfected South African Participants.
Saved in:
| Title: | Sequential Immunization with gp140 Boosts Immune Responses Primed by Modified Vaccinia Ankara or DNA in HIV-Uninfected South African Participants. |
|---|---|
| Authors: | Churchyard G; Aurum Institute for Health Research, Klerksdorp, South Africa.; School of Public Health, University of Witwatersrand, Johannesburg, South Africa.; Advancing Care and Treatment for TB and HIV, Medical Research Council Collaborating Centre, Klerksdorp, South Africa., Mlisana K; University of Kwa-Zulu Natal, Durban, South Africa., Karuna S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America., Williamson AL; Institute of Infectious Disease and Molecular Medicine, Division of Medical Virology, University of Cape Town, Cape Town, South Africa; National Health Laboratory Services, Observatory, Cape Town, South Africa., Williamson C; Institute of Infectious Disease and Molecular Medicine, Division of Medical Virology, University of Cape Town, Cape Town, South Africa; National Health Laboratory Services, Observatory, Cape Town, South Africa., Morris L; National Institute for Communicable Diseases, National Health Laboratory Services, Sandringham, Johannesburg, South Africa., Tomaras GD; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, United States of America., De Rosa SC; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.; Department of Laboratory Medicine, University of Washington, Seattle, WA, United States of America., Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America., Gu N; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America., Yu C; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America., Mkhize NN; National Institute for Communicable Diseases, National Health Laboratory Services, Sandringham, Johannesburg, South Africa., Hermanus T; National Institute for Communicable Diseases, National Health Laboratory Services, Sandringham, Johannesburg, South Africa., Allen M; Vaccine Research Program, Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America., Pensiero M; Vaccine Research Program, Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America., Barnett SW; Novartis Vaccines and Diagnostics, Cambridge, MA, United States of America., Gray G; South African Medical Research Council, Cape Town, South Africa.; Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Braamfontein, Johannesburg, South Africa., Bekker LG; Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Montefiori DC; Laboratory for AIDS Vaccine Research and Development, Duke University Medical Center, Durham, NC, United States of America., Kublin J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America., Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.; Department of Laboratory Medicine, University of Washington, Seattle, WA, United States of America. |
| Source: | PloS one [PLoS One] 2016 Sep 01; Vol. 11 (9), pp. e0161753. Date of Electronic Publication: 2016 Sep 01 (Print Publication: 2016). |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 27583368 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Sequential Immunization with gp140 Boosts Immune Responses Primed by Modified Vaccinia Ankara or DNA in HIV-Uninfected South African Participants. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Churchyard+G%22">Churchyard G</searchLink>; Aurum Institute for Health Research, Klerksdorp, South Africa.; School of Public Health, University of Witwatersrand, Johannesburg, South Africa.; Advancing Care and Treatment for TB and HIV, Medical Research Council Collaborating Centre, Klerksdorp, South Africa.<br /><searchLink fieldCode="AU" term="%22Mlisana+K%22">Mlisana K</searchLink>; University of Kwa-Zulu Natal, Durban, South Africa.<br /><searchLink fieldCode="AU" term="%22Karuna+S%22">Karuna S</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.<br /><searchLink fieldCode="AU" term="%22Williamson+AL%22">Williamson AL</searchLink>; Institute of Infectious Disease and Molecular Medicine, Division of Medical Virology, University of Cape Town, Cape Town, South Africa; National Health Laboratory Services, Observatory, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Williamson+C%22">Williamson C</searchLink>; Institute of Infectious Disease and Molecular Medicine, Division of Medical Virology, University of Cape Town, Cape Town, South Africa; National Health Laboratory Services, Observatory, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Morris+L%22">Morris L</searchLink>; National Institute for Communicable Diseases, National Health Laboratory Services, Sandringham, Johannesburg, South Africa.<br /><searchLink fieldCode="AU" term="%22Tomaras+GD%22">Tomaras GD</searchLink>; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, United States of America.<br /><searchLink fieldCode="AU" term="%22De+Rosa+SC%22">De Rosa SC</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.; Department of Laboratory Medicine, University of Washington, Seattle, WA, United States of America.<br /><searchLink fieldCode="AU" term="%22Gilbert+PB%22">Gilbert PB</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.<br /><searchLink fieldCode="AU" term="%22Gu+N%22">Gu N</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.<br /><searchLink fieldCode="AU" term="%22Yu+C%22">Yu C</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.<br /><searchLink fieldCode="AU" term="%22Mkhize+NN%22">Mkhize NN</searchLink>; National Institute for Communicable Diseases, National Health Laboratory Services, Sandringham, Johannesburg, South Africa.<br /><searchLink fieldCode="AU" term="%22Hermanus+T%22">Hermanus T</searchLink>; National Institute for Communicable Diseases, National Health Laboratory Services, Sandringham, Johannesburg, South Africa.<br /><searchLink fieldCode="AU" term="%22Allen+M%22">Allen M</searchLink>; Vaccine Research Program, Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.<br /><searchLink fieldCode="AU" term="%22Pensiero+M%22">Pensiero M</searchLink>; Vaccine Research Program, Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.<br /><searchLink fieldCode="AU" term="%22Barnett+SW%22">Barnett SW</searchLink>; Novartis Vaccines and Diagnostics, Cambridge, MA, United States of America.<br /><searchLink fieldCode="AU" term="%22Gray+G%22">Gray G</searchLink>; South African Medical Research Council, Cape Town, South Africa.; Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Braamfontein, Johannesburg, South Africa.<br /><searchLink fieldCode="AU" term="%22Bekker+LG%22">Bekker LG</searchLink>; Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Montefiori+DC%22">Montefiori DC</searchLink>; Laboratory for AIDS Vaccine Research and Development, Duke University Medical Center, Durham, NC, United States of America.<br /><searchLink fieldCode="AU" term="%22Kublin+J%22">Kublin J</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.<br /><searchLink fieldCode="AU" term="%22Corey+L%22">Corey L</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.; Department of Laboratory Medicine, University of Washington, Seattle, WA, United States of America. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101285081%22">PloS one</searchLink> [PLoS One] 2016 Sep 01; Vol. 11 (9), pp. e0161753. <i>Date of Electronic Publication: </i>2016 Sep 01 (<i>Print Publication: </i>2016). – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101285081 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1932-6203 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219326203%22">19326203 </searchLink><i>NLM ISO Abbreviation: </i>PLoS One <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=27583368 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1371/journal.pone.0161753 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e0161753 Titles: – TitleFull: Sequential Immunization with gp140 Boosts Immune Responses Primed by Modified Vaccinia Ankara or DNA in HIV-Uninfected South African Participants. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Churchyard G – PersonEntity: Name: NameFull: Mlisana K – PersonEntity: Name: NameFull: Karuna S – PersonEntity: Name: NameFull: Williamson AL – PersonEntity: Name: NameFull: Williamson C – PersonEntity: Name: NameFull: Morris L – PersonEntity: Name: NameFull: Tomaras GD – PersonEntity: Name: NameFull: De Rosa SC – PersonEntity: Name: NameFull: Gilbert PB – PersonEntity: Name: NameFull: Gu N – PersonEntity: Name: NameFull: Yu C – PersonEntity: Name: NameFull: Mkhize NN – PersonEntity: Name: NameFull: Hermanus T – PersonEntity: Name: NameFull: Allen M – PersonEntity: Name: NameFull: Pensiero M – PersonEntity: Name: NameFull: Barnett SW – PersonEntity: Name: NameFull: Gray G – PersonEntity: Name: NameFull: Bekker LG – PersonEntity: Name: NameFull: Montefiori DC – PersonEntity: Name: NameFull: Kublin J – PersonEntity: Name: NameFull: Corey L IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2016 Sep 01 Type: published Y: 2016 Identifiers: – Type: issn-electronic Value: 1932-6203 Numbering: – Type: volume Value: 11 – Type: issue Value: 9 Titles: – TitleFull: PloS one Type: main |
| ResultId | 1 |